Literature DB >> 26620798

Super-enhancer lncs to cardiovascular development and disease.

Samir Ounzain1, Thierry Pedrazzini2.   

Abstract

Cardiac development, function and pathological remodelling in response to stress depend on the dynamic control of tissue specific gene expression by distant acting transcriptional enhancers. Recently, super-enhancers (SEs), also known as stretch or large enhancer clusters, are emerging as sentinel regulators within the gene regulatory networks that underpin cellular functions. It is becoming increasingly evident that long noncoding RNAs (lncRNAs) associated with these sequences play fundamental roles for enhancer activity and the regulation of the gene programs hardwired by them. Here, we review this emerging landscape, focusing on the roles of SEs and their derived lncRNAs in cardiovascular development and disease. We propose that exploration of this genomic landscape could provide novel therapeutic targets and approaches for the amelioration of cardiovascular disease. Ultimately we envisage a future of ncRNA therapeutics targeting the SE landscape to alleviate cardiovascular disease. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Enhancers; Heart development; Heart failure; Long noncoding RNAs (lncRNA); Super-enhancers

Mesh:

Substances:

Year:  2015        PMID: 26620798     DOI: 10.1016/j.bbamcr.2015.11.026

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  The long noncoding RNA Wisper controls cardiac fibrosis and remodeling.

Authors:  Rudi Micheletti; Isabelle Plaisance; Brian J Abraham; Alexandre Sarre; Ching-Chia Ting; Michael Alexanian; Daniel Maric; Damien Maison; Mohamed Nemir; Richard A Young; Blanche Schroen; Arantxa González; Samir Ounzain; Thierry Pedrazzini
Journal:  Sci Transl Med       Date:  2017-06-21       Impact factor: 17.956

Review 2.  Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure.

Authors:  Rachel A Minerath; Duane D Hall; Chad E Grueter
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

3.  Long non-coding RNAs in heart failure: a promising future with much to learn.

Authors:  Samir Ounzain; Thierry Pedrazzini
Journal:  Ann Transl Med       Date:  2016-08

Review 4.  Epigenetic regulation of cardiac fibrosis.

Authors:  Matthew S Stratton; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2016-02-12       Impact factor: 5.000

Review 5.  Role of lncRNAs in Cellular Aging.

Authors:  Ufuk Degirmenci; Sun Lei
Journal:  Front Endocrinol (Lausanne)       Date:  2016-12-06       Impact factor: 5.555

6.  eRFSVM: a hybrid classifier to predict enhancers-integrating random forests with support vector machines.

Authors:  Fang Huang; Jiawei Shen; Qingli Guo; Yongyong Shi
Journal:  Hereditas       Date:  2016-06-30       Impact factor: 3.271

7.  A transcribed enhancer dictates mesendoderm specification in pluripotency.

Authors:  Michael Alexanian; Daniel Maric; Stephen P Jenkinson; Marco Mina; Clayton E Friedman; Ching-Chia Ting; Rudi Micheletti; Isabelle Plaisance; Mohamed Nemir; Damien Maison; Jasmin Kernen; Iole Pezzuto; Dominic Villeneuve; Frédéric Burdet; Mark Ibberson; Stephen L Leib; Nathan J Palpant; Nouria Hernandez; Samir Ounzain; Thierry Pedrazzini
Journal:  Nat Commun       Date:  2017-11-27       Impact factor: 14.919

8.  Super-enhancers in transcriptional regulation and genome organization.

Authors:  Xi Wang; Murray J Cairns; Jian Yan
Journal:  Nucleic Acids Res       Date:  2019-12-16       Impact factor: 16.971

Review 9.  Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis.

Authors:  Yuan Tan; Yuejin Li; Faqing Tang
Journal:  Mol Cancer       Date:  2020-04-11       Impact factor: 27.401

10.  The Role of Long Non-coding RNAs in the Pathogenesis of RA, SLE, and SS.

Authors:  Yunzhen Gao; Shasha Li; Zhongjian Zhang; Xinhua Yu; Junfeng Zheng
Journal:  Front Med (Lausanne)       Date:  2018-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.